A Pex7 hypomorphic mouse model for plasmalogen deficiency affecting the lens and skeleton

Molecular Genetics and Metabolism

Volumn 99, Issue 4, 2010, Pages 408-416

  Braverman, Nancy ^a   Zhang, Rui ^b   Chen, Li ^b   Nimmo, Graeme ^a   Scheper, Sarah ^b   Tran, Tammy ^b   Chaudhury, Rupsa ^b   Moser, Ann ^c   Steinberg, Steven ^c  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Mouse models; Peroxisome biogenesis disorder; Pex7; Phytanic acid; Plasmalogens; Rhizomelic chondrodysplasia punctata

Indexed keywords

ALCOHOL DERIVATIVE; BATILOL; CELL RECEPTOR; PEROXISOME RECEPTOR 7; PHOSPHOLIPID; PHYTANIC ACID; PLASMALOGEN; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BLOOD SAMPLING; BONE DISEASE; CATARACT; CELL FUNCTION; CHONDRODYSPLASIA PUNCTATA; CONTROLLED STUDY; DIET SUPPLEMENTATION; EMBRYO; ENCHONDRAL OSSIFICATION; FERTILITY; GENETIC TRANSCRIPTION; HUMAN; LENS DISEASE; LENS FIBER; LIFESPAN; MORTALITY; MOUSE; NONHUMAN; OXIDATION; PHENOTYPE; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; BONE AND BONES; CELLS, CULTURED; CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; GLYCERYL ETHERS; LENS, CRYSTALLINE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PEROXISOMES; PHENOTYPE; PHYTANIC ACID; PLASMALOGENS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TISSUE DISTRIBUTION;

ANIMALIA; MUS;

EID: 77649341208     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2009.12.005     Document Type: Article

References (53)

1. White A.L., Modaff P., Holland-Morris F., and Pauli R.M. Natural history of rhizomelic chondrodysplasia punctata. Am. J. Med. Genet. 118A (2003) 332-342
2. Steinberg S.J., Dodt G., Raymond G.V., Braverman N.E., Moser A.B., and Moser H.W. Peroxisome biogenesis disorders. Biochim. Biophys. Acta 1763 (2006) 1733-1748
3. Powers J.M., Kenjarski T.P., Moser A.B., and Moser H.W. Cerebellar atrophy in chronic rhizomelic chondrodysplasia punctata: a potential role for phytanic acid and calcium in the death of its Purkinje cells. Acta Neuropathol. (Berl.) 98 (1999) 129-134
4. Bams-Mengerink A.M., Majoie C.B., Duran M., Wanders R.J., Van Hove J., Scheurer C.D., Barth P.G., and Poll-The B.T. MRI of the brain and cervical spinal cord in rhizomelic chondrodysplasia punctata. Neurology 66 (2006) 798-803 (discussion 789)
5. Braverman N., Steel G., Obie C., Moser A., Moser H., Gould S.J., and Valle D. Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata. Nat. Genet. 15 (1997) 369-376
6. Wanders R.J., and Waterham H.R. Biochemistry of mammalian peroxisomes revisited. Ann. Rev. Biochem. 75 (2006) 295-332
7. Braverman N., Chen L., Lin P., Obie C., Steel G., Douglas P., Chakraborty P.K., Clarke J.T., Boneh A., Moser A., Moser H., and Valle D. Mutation analysis of PEX7 in 60 probands with rhizomelic chondrodysplasia punctata and functional correlations of genotype with phenotype. Hum. Mutat. 20 (2002) 284-297
8. Nagan N., and Zoeller R.A. Plasmalogens: biosynthesis and functions. Prog. Lipid Res. 40 (2001) 199-229
9. Brites P., Waterham H.R., and Wanders R.J. Functions and biosynthesis of plasmalogens in health and disease. Biochim. Biophys. Acta 1636 (2004) 219-231
10. Rapport M.M., and Lerner B. The structure of plasmalogens. IV. Lipids in normal and neoplastic tissues of man and in normal tissues of rabbit and rat. Biochim. Biophys. Acta 33 (1959) 319-325
11. Zhang Y., Hayashi Y., Cheng X., Watanabe T., Wang X., Taniguchi N., and Honke K. Testis-specific sulfoglycolipid, seminolipid, is essential for germ cell function in spermatogenesis. Glycobiology 15 (2005) 649-654
12. Lohner K. Is the high propensity of ethanolamine plasmalogens to form non-lamellar lipid structures manifested in the properties of biomembranes?. Chem. Phys. Lipids 81 (1996) 167-184
13. Pike L.J., Han X., Chung K.N., and Gross R.W. Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis. Biochemistry 41 (2002) 2075-2088
14. Hale C.C., Ebeling E.G., Hsu F.F., and Ford D.A. The selective activation of the cardiac sarcolemmal sodium-calcium exchanger by plasmalogenic phosphatidic acid produced by phospholipase D. FEBS Lett. 422 (1998) 247-251
15. Styger R., Wiesmann U.N., and Honegger U.E. Plasmalogen content and beta-adrenoceptor signalling in fibroblasts from patients with Zellweger syndrome. Effects of hexadecylglycerol. Biochim. Biophys. Acta 1585 (2002) 39-43
16. Meyer M.C., Rastogi P., Beckett C.S., and McHowat J. Phospholipase A2 inhibitors as potential anti-inflammatory agents. Curr. Pharm. Des. 11 (2005) 1301-1312
17. Panneels V., Macours P., Van den Bergen H., Braekman J.C., Van Sande J., and Boeynaems J.M. Biosynthesis and metabolism of 2-iodohexadecanal in cultured dog thyroid cells. J. Biol. Chem. 271 (1996) 23006-23014
18. Skaff O., Pattison D.I., and Davies M.J. The vinyl ether linkages of plasmalogens are favored targets for myeloperoxidase-derived oxidants: a kinetic study. Biochemistry 47 (2008) 8237-8245
19. Zoeller R.A., Grazia T.J., LaCamera P., Park J., Gaposchkin D.P., and Farber H.W. Increasing plasmalogen levels protects human endothelial cells during hypoxia. Am. J. Physiol. Heart Circ. Physiol. 283 (2002) H671-H679
20. Rudiger M., Tolle A., Meier W., and Rustow B. Naturally derived commercial surfactants differ in composition of surfactant lipids and in surface viscosity. Am. J. Physiol. Lung Cell. Mol. Physiol. 288 (2005) L379-L383
21. Munn N.J., Arnio E., Liu D., Zoeller R.A., and Liscum L. Deficiency in ethanolamine plasmalogen leads to altered cholesterol transport. J. Lipid Res. 44 (2003) 182-192
22. Hartmann T., Kuchenbecker J., and Grimm M.O. Alzheimer's disease: the lipid connection. J. Neurochem. 103 Suppl. 1 (2007) 159-170
23. Rudiger M., von Baehr A., Haupt R., Wauer R.R., and Rustow B. Preterm infants with high polyunsaturated fatty acid and plasmalogen content in tracheal aspirates develop bronchopulmonary dysplasia less often. Crit. Care Med. 28 (2000) 1572-1577
24. Huang L., Grami V., Marrero Y., Tang D., Yappert M.C., Rasi V., and Borchman D. Human lens phospholipid changes with age and cataract. Invest. Ophthalmol. Vis. Sci. 46 (2005) 1682-1689
25. Brites P., Motley A.M., Gressens P., Mooyer P.A., Ploegaert I., Everts V., Evrard P., Carmeliet P., Dewerchin M., Schoonjans L., Duran M., Waterham H.R., Wanders R.J., and Baes M. Impaired neuronal migration and endochondral ossification in Pex7 knockout mice. a model for rhizomelic chondrodysplasia punctata. Hum. Mol. Genet. 12 (2003) 2255-2267
26. Rodemer C., Thai T.P., Brugger B., Kaercher T., Werner H., Nave K.A., Wieland F., Gorgas K., and Just W.W. Inactivation of ether lipid biosynthesis causes male infertility, defects in eye development and optic nerve hypoplasia in mice. Hum. Mol. Genet. 12 (2003) 1881-1895
27. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
28. Dacremont G., Cocquyt G., and Vincent G. Measurement of very long-chain fatty acids, phytanic and pristanic acid in plasma and cultured fibroblasts by gas chromatography. J. Inherit. Metab. Dis. 18 Suppl. 1 (1995) 76-83
29. Dacremont G., and Vincent G. Assay of plasmalogens and polyunsaturated fatty acids (PUFA) in erythrocytes and fibroblasts. J. Inherit. Metab. Dis. 18 Suppl. 1 (1995) 84-89
30. Roscher A., Molzer B., Bernheimer H., Stockler S., Mutz I., and Paltauf F. The cerebrohepatorenal (Zellweger) syndrome: an improved method for the biochemical diagnosis and its potential value for prenatal detection. Pediatr. Res. 19 (1985) 930-933
31. Meyers E.N., Lewandoski M., and Martin G.R. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat. Genet. 18 (1998) 136-141
32. Nagy A., Moens C., Ivanyi E., Pawling J., Gertsenstein M., Hadjantonakis A.K., Pirity M., and Rossant J. Dissecting the role of N-myc in development using a single targeting vector to generate a series of alleles. Curr. Biol. 8 (1998) 661-664
33. Horn M.A., van den Brink D.M., Wanders R.J., Duran M., Poll-The B.T., Tallaksen C.M., Stokke O.H., Moser H., and Skjeldal O.H. Phenotype of adult Refsum disease due to a defect in peroxin 7. Neurology 68 (2007) 698-700
34. Ellinghaus P., Wolfrum C., Assmann G., Spener F., and Seedorf U. Phytanic acid activates the peroxisome proliferator-activated receptor alpha (PPARalpha) in sterol carrier protein 2-/sterol carrier protein x-deficient mice. J. Biol. Chem. 274 (1999) 2766-2772
35. Das A.K., Holmes R.D., Wilson G.N., and Hajra A.K. Dietary ether lipid incorporation into tissue plasmalogens of humans and rodents. Lipids 27 (1992) 401-405
36. Rizzo W.B., Heinz E., Simon M., and Craft D.A. Microsomal fatty aldehyde dehydrogenase catalyzes the oxidation of aliphatic aldehyde derived from ether glycerolipid catabolism: implications for Sjogren-Larsson syndrome. Biochim. Biophys. Acta 1535 (2000) 1-9
37. Theander G., and Pettersson H. Calcification in chondrodysplasia punctata. Relation to ossification and skeletal growth. Acta Radiol. Diagn. (Stockh.) 19 (1978) 205-222
38. Derry J.M., Gormally E., Means G.D., Zhao W., Meindl A., Kelley R.I., Boyd Y., and Herman G.E. Mutations in a delta 8-delta 7 sterol isomerase in the tattered mouse and X-linked dominant chondrodysplasia punctata. Nat. Genet. 22 (1999) 286-290
39. Luo G., Ducy P., McKee M.D., Pinero G.J., Loyer E., Behringer R.R., and Karsenty G. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386 (1997) 78-81
40. Poulos A., Sheffield L., Sharp P., Sherwood G., Johnson D., Beckman K., Fellenberg A.J., Wraith J.E., Chow C.W., Usher S., et al. Rhizomelic chondrodysplasia punctata: clinical, pathologic, and biochemical findings in two patients. J. Pediatr. 113 (1988) 685-690
41. Gaposchkin D.P., and Zoeller R.A. Plasmalogen status influences docosahexaenoic acid levels in a macrophage cell line. Insights using ether lipid-deficient variants. J. Lipid Res. 40 (1999) 495-503
42. Ferdinandusse S., Zomer A.W., Komen J.C., van den Brink C.E., Thanos M., Hamers F.P., Wanders R.J., van der Saag P.T., Poll-The B.T., and Brites P. Ataxia with loss of Purkinje cells in a mouse model for Refsum disease. Proc. Natl. Acad. Sci. USA 105 (2008) 17712-17717
43. Savolainen K., Kotti T.J., Schmitz W., Savolainen T.I., Sormunen R.T., Ilves M., Vainio S.J., Conzelmann E., and Hiltunen J.K. A mouse model for alpha-methylacyl-CoA racemase deficiency: adjustment of bile acid synthesis and intolerance to dietary methyl-branched lipids. Hum. Mol. Genet. 13 (2004) 955-965
44. Mackie J.T., Atshaves B.P., Payne H.R., McIntosh A.L., Schroeder F., and Kier A.B. Phytol-induced hepatotoxicity in mice. Toxicol. Pathol. 37 (2009) 201-208
45. Farooqui A.A., Ong W.Y., and Horrocks L.A. Plasmalogens, docosahexaenoic acid and neurological disorders. Adv. Exp. Med. Biol. 544 (2003) 335-354
46. Gonzalez F.J., and Shah Y.M. PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators. Toxicology 246 (2008) 2-8
47. Wilson G.N., Holmes R.G., Custer J., Lipkowitz J.L., Stover J., Datta N., and Hajra A. Zellweger syndrome: diagnostic assays, syndrome delineation, and potential therapy. Am. J. Med. Genet. 24 (1986) 69-82
48. Blank M.L., Cress E.A., Smith Z.L., and Snyder F. Dietary supplementation with ether-linked lipids and tissue lipid composition. Lipids 26 (1991) 166-169
49. Farooqui A.A., Ong W.Y., and Horrocks L.A. Plasmalogens, docosahexaenoic acid and neurological disorders. Adv. Exp. Med. Biol. 544 (2003) 335-354
50. Krass K.L., Colinayo V., Ghazalpour A., Vinters H.V., Lusis A.J., and Drake T.A. Genetic loci contributing to age-related hippocampal lesions in mice. Neurobiol. Dis. 13 (2003) 102-108
51. Teigler A., Komljenovic D., Draguhn A., Gorgas K., and Just W.W. Defects in myelination, paranode organization and Purkinje cell innervation in the ether lipid-deficient mouse cerebellum. Hum. Mol. Genet. 18 (2009) 1897-1908
52. Komljenovic D., Sandhoff R., Teigler A., Heid H., Just W.W., and Gorgas K. Disruption of blood-testis barrier dynamics in ether-lipid-deficient mice. Cell Tissue Res. 337 (2009) 281-299
53. Brites P., Mooyer P.A., El Mrabet L., Waterham H.R., and Wanders R.J. Plasmalogens participate in very-long-chain fatty acid-induced pathology. Brain 132 (2009) 482-492